8 Analysts Have This to Say About Roivant Sciences
Portfolio Pulse from Benzinga Insights
In the last quarter, Roivant Sciences (NASDAQ:ROIV) received 5 bullish, 2 somewhat bullish, and 1 indifferent rating from analysts. The company's average price target has increased by 11.29% from the previous average of $15.33 to $17.06. The high and low price targets are $23.00 and $10.50 respectively.
August 15, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roivant Sciences has received predominantly positive ratings from analysts, with an increased average price target. This could potentially boost investor confidence and positively impact the stock price in the short term.
Analyst ratings often influence investor sentiment and can impact stock prices. In this case, the majority of the ratings for Roivant Sciences are bullish, and the average price target has increased, indicating a positive outlook for the company. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100